On ECHEMI
Home > Drugs > Lacosamide Registered Holders
Lacosamide structure

Lacosamide structure

Lacosamide

White to Off-White SolidLacosamide (LCM), (SPM 927, (R)-2-acetamido-N-benzyl-3-methoxypropionamide, previously referred to as harkoseride or ADD 234037) is a member of a series of functionalized amino acids that were specifically synthesized as anticonvulsant or antiepileptic drug. It reduces the spread of seizure activity in the brain. Lacosamide appears to have a dual mode of action: selective enhancement of sodium channel inactivation and modulation of collapsin response mediator protein-2. 

Find 67 Related Holders

Unichem Laboratories Ltd
United States United States

API Registration Country

API Active
CHIERON ACTIVE INGREDIENTS PRIVATE LTD
United States United States

API Registration Country

API Active
BEIJING HOPE PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
WISDOM PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
VIYASH SCIENTIFIC LIMITED
European Union European Union

API Registration Country

API Active
Cambrex Profarmaco Milano S.r.l.
European Union European Union

API Registration Country

API Active
LEE PHARMA LIMITED
European Union European Union

API Registration Country

API Active
VIYASH LIFE SCIENCES PRIVATE LTD
United States United States

API Registration Country

API Active
EMNAR PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
WISDOM PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Active
Recommended Suppliers of Lacosamide
View 97 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.